By G HossainPosted on July 10, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Roche’s decision to discontinue the Ionis-partnered trials came soon after the biotech sustained a late-stage failure in ATTR-CM. Roche scraps 2 Huntington’s studies, handing Ionis more bad news Post navigation Amgen continues to defend Tavneos as global regulatory pressure mountsGSK and Hansoh’s ADC clinches late-stage win, teeing up regulatory submission in China
